New chemo strategy may spare sinus cancer patients from major surgery
NCT ID NCT07320508
First seen Jan 11, 2026 · Last updated May 14, 2026 · Updated 17 times
Summary
This study tests a new approach for a rare sinus cancer that often spreads along nerves. About 100 adults with advanced tumors will receive three sessions of targeted chemotherapy directly into the tumor's blood supply. If the tumor disappears on scans, patients may avoid surgery and get radiation only; otherwise, they'll have surgery plus radiation. The goal is to improve outcomes while possibly reducing the need for extensive surgery.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADENOID CYSTIC CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Eye and ENT Hospital, Fudan University
RECRUITINGShanghai, Xuhui Strict, 200031, China
Conditions
Explore the condition pages connected to this study.